Hypothesized mechanisms of resistance include genetic loss of β2 microglobulin, reduced tumor infiltrating lymphocytes, antigen loss, signaling disruption, ineffective CD8+ T-cell function, upregulation of alternative immune checkpoints, or loss of downstream signaling via JAK1/2 gene modifications [85–87]. Here, CD8A is linked to neoplasm.